Wei Duan
Professor Wei Duan graduated with a MD from Shanghai University of Chinese Medicine and obtained his Ph.D. in Biochemistry and Molecular Biology at University of Melbourne in 1991. He is currently a professor of cancer therapeutics at Deakin University School of Medicine in Melbourne, Australia.
Prof. Duan has published more than 200 original research papers and review articles in peer-reviewed journals with an h-index of 40. His main research interest is the application of aptamer technology in targeted drug delivery, extracellular vesicles and liquid biopsy for cancer. His work is supported by grants from National Health and Medical Research Council in Australia, Australian Research Council, and Australia-Indian Strategic Research Fund, Victoria Cancer Agency, and CASS Foundation as well as industry (GeneParma, China).
Prof. Duan serves on the editorial board of several scientific journals, including being the Editor-in-Chief of Drug Design, Development and Therapy between 2015-2016. He was also 2017 Clarivate Analytics’ Highly Cited Researcher in Pharmacology/Toxicology,
Abstracts this author is presenting: